Product Code: 1155
The clinical trial management system market is set to witness sturdy growth through 2030 owing to proliferating number of clinical studies in key regions worldwide. Additionally, increasing focus on strengthening the global healthcare system, along with the growing pharmaceuticals industry, is set to further support industry growth over the forecast timeframe.
Notably, industry players have been adopting profitable strategies to improve their business presence, fostering the clinical trial management system (CTMS) market outlook. For instance, in June 2022, Medidata, a major provider of software as a service (SaaS) for clinical trials, introduced technology enhancements to its Medidata Detect and Rave CTMS to address concerns regarding clinical trial management and oversight. These enhancements were designed to improve both data reporting and oversight for contract research organizations and sponsors in the way they monitor as well as visualize trial data to enable faster decision-making.
In another notable development, in April 2022, Veeva Systems, a firm specializing in cloud-based solutions for pharmaceutical and life sciences applications, announced the global implementation of Veeva Vault CTMS by pharma behemoth Bristol Myers Squibb to drive end-to-end trial management. The new CTMS is integrated with Veeva's Study Startup and eTMF applications.
The clinical trial management system market has been bifurcated on the basis of product, end-use, component, delivery mode, and region.
From the product perspective, the market has been segregated into site based and enterprise based. The site based segment exceeded $334.7 million in revenue in 2021 and is expected to register significant growth in the upcoming time period.
In terms of end-use, the market has been divided into clinical research organizations, pharmaceutical and biopharmaceutical companies, and others. In 2021, the clinical research organizations segment was valued at more than $407.7 million and is speculated to amass considerable gains over 2022-2030.
By component, the clinical trial management system market has been segmented into services and software. The services segment is poised to register robust growth at a CAGR of about 11.8% between 2022 and 2030.
Based on delivery mode, the market has been divided into cloud-based, on-premise, and web-based. Among these, the cloud-based segment is anticipated to observe notable expansion to attain a valuation of around $793.0 million by the end of 2030.
On the regional front, the Latin America clinical trial management system market accounted for nearly 8.6% of the overall industry revenue in 2021 and is projected to witness considerable progress in the forthcoming years. Meanwhile, the Middle East & Africa clinical trial management system industry is estimated to grow at above 11.9% CAGR over the analysis period.
Table of Contents
Chapter 1 Methodology
- 1.1 Market definitions
- 1.2 Base estimates & working
- 1.3 Forecast parameters
- 1.4 Data validation
- 1.5 Data Sources
- 1.5.1 Secondary
- 1.5.1.1 Paid sources
- 1.5.1.2 Unpaid sources
- 1.5.2 Primary
Chapter 2 Executive Summary
- 2.1 Clinical trial management system industry 360 degree synopsis, 2017 - 2030
- 2.1.1 Business trends
- 2.1.2 Component trends
- 2.1.3 Product trends
- 2.1.4 Delivery mode trends
- 2.1.5 End-use trends
- 2.1.6 Regional trends
Chapter 3 Clinical trial management system (CTMS) Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry landscape, 2017 - 2030
- 3.3 Industry impact forces
- 3.3.1 Growth drivers
- 3.3.1.1 Growing chronic disease prevalence, effective medicine demand and modern technology adoption
- 3.3.1.2 Growing research and development activities
- 3.3.1.3 Increasing number of clinical trials
- 3.3.2 Industry pitfalls & challenges
- 3.3.2.1 High cost of clinical trial management system
- 3.4 Growth potential analysis
- 3.4.1 By component
- 3.4.2 By product
- 3.4.3 By delivery mode
- 3.4.4 By end-use
- 3.5 COVID-19 impact analysis
- 3.6 Software landscape
- 3.7 Regulatory landscape
- 3.7.1 U.S.
- 3.7.2 Europe
- 3.7.3 China
- 3.8 Porter's analysis
- 3.9 Competitive landscape
- 3.9.1 Company matrix analysis, 2021
- 3.10 PESTEL analysis
Chapter 4 Clinical trial management system (CTMS) Market, By Component
- 4.1 Key segment trends
- 4.2 Software
- 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3 Services
- 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 5 Clinical trial management system (CTMS) Market, By Product
- 5.1 Key segment trends
- 5.2 Enterprise-based
- 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.3 Site-based
- 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 6 Clinical trial management system (CTMS) Market, By Delivery Mode
- 6.1 Key segment trends
- 6.2 Web-based
- 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.3 Cloud-based
- 6.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.4 On premise
- 6.4.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 7 Clinical trial management system (CTMS) Market, By End-use
- 7.1 Key segment trends
- 7.2 Pharmaceutical & biopharmaceutical companies
- 7.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 7.3 Clinical research organization (CRO)
- 7.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 7.4 Others
- 7.4.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 8 Clinical trial management system (CTMS) Market, By Region
- 8.1 Key regional trends
- 8.2 North America
- 8.2.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.2.2 Market size, by component, 2017 - 2030 (USD Million)
- 8.2.3 Market size, by product, 2017 - 2030 (USD Million)
- 8.2.4 Market size, by delivery mode, 2017 - 2030 (USD Million)
- 8.2.5 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.2.6 U.S.
- 8.2.6.1 Market size, by component, 2017 - 2030 (USD Million)
- 8.2.6.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.2.6.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
- 8.2.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.2.7 Canada
- 8.2.7.1 Market size, by component, 2017 - 2030 (USD Million)
- 8.2.7.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.2.7.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
- 8.2.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3 Europe
- 8.3.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.3.2 Market size, by component, 2017 - 2030 (USD Million)
- 8.3.3 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.4 Market size, by delivery mode, 2017 - 2030 (USD Million)
- 8.3.5 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3.6 Germany
- 8.3.6.1 Market size, by component, 2017 - 2030 (USD Million)
- 8.3.6.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.6.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
- 8.3.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3.7 UK
- 8.3.7.1 Market size, by component, 2017 - 2030 (USD Million)
- 8.3.7.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.7.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
- 8.3.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3.8 France
- 8.3.8.1 Market size, by component, 2017 - 2030 (USD Million)
- 8.3.8.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.8.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
- 8.3.8.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3.9 Spain
- 8.3.9.1 Market size, by component, 2017 - 2030 (USD Million)
- 8.3.9.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.9.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
- 8.3.9.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3.10 Italy
- 8.3.10.1 Market size, by component, 2017 - 2030 (USD Million)
- 8.3.10.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.10.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
- 8.3.10.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.4 Asia Pacific
- 8.4.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.4.2 Market size, by component, 2017 - 2030 (USD Million)
- 8.4.3 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.4 Market size, by delivery mode, 2017 - 2030 (USD Million)
- 8.4.5 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.4.6 China
- 8.4.6.1 Market size, by component, 2017 - 2030 (USD Million)
- 8.4.6.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.6.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
- 8.4.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.4.7 Japan
- 8.4.7.1 Market size, by component, 2017 - 2030 (USD Million)
- 8.4.7.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.7.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
- 8.4.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.4.8 India
- 8.4.8.1 Market size, by component, 2017 - 2030 (USD Million)
- 8.4.8.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.8.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
- 8.4.8.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.4.9 Australia
- 8.4.9.1 Market size, by component, 2017 - 2030 (USD Million)
- 8.4.9.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.9.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
- 8.4.9.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.5 Latin America
- 8.5.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.5.2 Market size, by component, 2017 - 2030 (USD Million)
- 8.5.3 Market size, by product, 2017 - 2030 (USD Million)
- 8.5.4 Market size, by delivery mode, 2017 - 2030 (USD Million)
- 8.5.5 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.5.6 Brazil
- 8.5.6.1 Market size, by component, 2017 - 2030 (USD Million)
- 8.5.6.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.5.6.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
- 8.5.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.5.7 Mexico
- 8.5.7.1 Market size, by component, 2017 - 2030 (USD Million)
- 8.5.7.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.5.7.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
- 8.5.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.6 MEA
- 8.6.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.6.2 Market size, by component, 2017 - 2030 (USD Million)
- 8.6.3 Market size, by product, 2017 - 2030 (USD Million)
- 8.6.4 Market size, by delivery mode, 2017 - 2030 (USD Million)
- 8.6.5 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.6.6 South Africa
- 8.6.6.1 Market size, by component, 2017 - 2030 (USD Million)
- 8.6.6.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.6.6.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
- 8.6.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.6.7 Saudi Arabia
- 8.6.7.1 Market size, by component, 2017 - 2030 (USD Million)
- 8.6.7.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.6.7.3 Market size, by delivery mode, 2017 - 2030 (USD Million)
- 8.6.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
Chapter 9 Company Profiles
- 9.1 Competitive dashboard
- 9.2 Clario
- 9.2.1 Business overview
- 9.2.2 Financial data
- 9.2.3 Product landscape
- 9.2.4 Strategic outlook
- 9.2.5 SWOT analysis
- 9.3 Advarra
- 9.3.1 Business overview
- 9.3.2 Financial data
- 9.3.3 Product landscape
- 9.3.4 Strategic outlook
- 9.3.5 SWOT analysis
- 9.4 Datatrak Inc
- 9.4.1 Business overview
- 9.4.2 Financial data
- 9.4.3 Product landscape
- 9.4.4 Strategic outlook
- 9.4.5 SWOT analysis
- 9.5 PHARMASEAL
- 9.5.1 Business overview
- 9.5.2 Financial data
- 9.5.3 Product landscape
- 9.5.4 Strategic outlook
- 9.5.5 SWOT analysis
- 9.6 SimpleTrials
- 9.6.1 Business overview
- 9.6.2 Financial data
- 9.6.3 Product landscape
- 9.6.4 Strategic outlook
- 9.6.5 SWOT analysis
- 9.7 MasterControl Inc
- 9.7.1 Business overview
- 9.7.2 Financial data
- 9.7.3 Product landscape
- 9.7.4 Strategic outlook
- 9.7.5 SWOT analysis
- 9.8 Medidata Solution Inc (Dassault Systemes)
- 9.8.1 Business overview
- 9.8.2 Financial data
- 9.8.3 Product landscape
- 9.8.4 Strategic outlook
- 9.8.5 SWOT analysis
- 9.9 MedNet Solution Inc
- 9.9.1 Business overview
- 9.9.2 Financial data
- 9.9.3 Product landscape
- 9.9.4 Strategic outlook
- 9.9.5 SWOT analysis
- 9.10 Merge Healthcare (IBM Watson)
- 9.10.1 Business overview
- 9.10.2 Financial data
- 9.10.3 Product landscape
- 9.10.4 Strategic outlook
- 9.10.5 SWOT analysis
- 9.11 Anju Software Inc
- 9.11.1 Business overview
- 9.11.2 Financial data
- 9.11.3 Product landscape
- 9.11.4 Strategic outlook
- 9.11.5 SWOT analysis
- 9.12 Oracle Corporation
- 9.12.1 Business overview
- 9.12.2 Financial data
- 9.12.3 Product landscape
- 9.12.4 Strategic outlook
- 9.12.5 SWOT analysis
- 9.13 Paraxel International
- 9.13.1 Business overview
- 9.13.2 Financial data
- 9.13.3 Product landscape
- 9.13.4 Strategic outlook
- 9.13.5 SWOT analysis
- 9.14 Veeva System
- 9.14.1 Business overview
- 9.14.2 Financial data
- 9.14.3 Product landscape
- 9.14.4 Strategic outlook
- 9.14.5 SWOT analysis